Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-25-003362
Filing Date
2025-05-12
Accepted
2025-05-12 06:03:10
Documents
14

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 cns_s1a1.htm   iXBRL S-1/A 373240
  Complete submission text file 0001683168-25-003362.txt   600644

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cnsp-20250512.xsd EX-101.SCH 3017
3 XBRL LABEL FILE cnsp-20250512_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE cnsp-20250512_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT cns_s1a1_htm.xml XML 3138
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-286529 | Film No.: 25932385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)